{"schemaVersion":"ready-scan.discovery-surface.v1","id":"urn:readyscan:corpus:buyer-question:mitaky-q125422561-answer-f89a83fe2fc6d2d3be0c","key":"buyer_question:mitaky-q125422561-answer-f89a83fe2fc6d2d3be0c","kind":"buyer_question","slug":"mitaky-q125422561-answer-f89a83fe2fc6d2d3be0c","canonicalUrl":"https://directory.readyscan.ai/corpus/buyer-question/mitaky-q125422561-answer-f89a83fe2fc6d2d3be0c","machineUrl":"https://directory.readyscan.ai/discovery/corpus/buyer-question/mitaky-q125422561-answer-f89a83fe2fc6d2d3be0c.json","datePublished":"2026-10-22","dateModified":"2026-10-22","materialFingerprint":"fnv1a64:506f2f743cdaaf80","membershipFingerprint":"fnv1a64:af0e8f8b2978ae51","relatedEntitySlugs":["mitaky-q125422561"],"relatedSurfaceKeys":["buyer_question:mitaky-q125422561-answer-26107b3485ec4b5bed67","buyer_question:mitaky-q125422561-answer-26214215ddf8c57c21c2","buyer_question:mitaky-q125422561-answer-28f405964cfa21435913","buyer_question:mitaky-q125422561-answer-2f098f50ffdc018bbe0f","buyer_question:mitaky-q125422561-answer-67194cec82646f2730c7","buyer_question:mitaky-q125422561-answer-6945ad974130523ec258","buyer_question:mitaky-q125422561-answer-7275a440b0807c7e491f","buyer_question:mitaky-q125422561-answer-818eae6d67e588931a5b","buyer_question:mitaky-q125422561-answer-cf1345e4652cbcc429b6","buyer_question:mitaky-q125422561-answer-d809d3484c64f2e794ea","buyer_question:mitaky-q125422561-answer-dda3088f82f948d44936","buyer_question:mitaky-q125422561-answer-e70565b30a670e9b6dfb","evidence:mitaky-q125422561"],"sourceIds":["ready-scan-subjects"],"provenance":[{"snapshotId":"mitaky-q125422561-content-65b618f9ad53d651-snapshot","sourceId":"ready-scan-subjects","sourceRecordId":"Q125422561","sourceRevisionId":"Q125422561:content:f666444add2d8b17","sourceContentHash":"fnv1a64:0cde2888f2848a61","recordRevisionId":"Q125422561:content:f666444add2d8b17","recordContentHash":"fnv1a64:5f3bde14b04eee9b","sourceCanonicalUrl":"https://mitaky.co.jp/","sourceModifiedAt":"2026-10-22T11:27:20.950Z","observedOn":"2026-10-22","permission":{"basis":"public_information","evidenceUrl":"https://mitaky.co.jp/"},"attributionUrl":"https://mitaky.co.jp/"}],"quality":{"method":"same_kind_unique_trigram_floor","minimumUniqueTrigramRatio":0.3,"status":"passed"},"title":"Q1. Is ADSC therapy safe?","summary":"Cited source answers across 1 active corpus record.","question":"Q1. Is ADSC therapy safe?","answers":[{"entitySlug":"mitaky-q125422561","entityName":"MITAKY","answer":"“Yes, ADSC therapy is safe as it uses autologous cells (your own), minimising the risk of immune rejection and adverse reactions. All procedures are conducted under stringent medical guidelines in CPC-certified facilities by Japan’s Ministry of Health, Labour & Welfare, to ensure the highest standards of safety and quality.”","sourceUrls":["https://mitaky.co.jp/products-services/japanese-adipose-derived-stem-cell-therapy/"]}]}